2Année·

Small first additional purchase, if it falls even lower, even more ...


If Motley Fool wants to go "all in", it would be stupid not to risk another ant as well


Closer

18.01
BioCryst Pharms logo
Acheté à 13,60 €
4 Commentaires

image de profil
First ant position , second NVIDIA has KUV 40 and apparently Biocryst has a unique selling proposition with its drug
Afficher la réponse
image de profil
Since when does Motley Fool go "all in" anywhere?
Voir toutes les 2 autres réponses
Participez à la conversation